Exodus Point Capital Management, LP Syndax Pharmaceuticals Inc Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 318,394 shares of SNDX stock, worth $3.99 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
318,394
Previous 625,723
49.12%
Holding current value
$3.99 Million
Previous $12.8 Million
52.29%
% of portfolio
0.04%
Previous 0.09%
Shares
11 transactions
Others Institutions Holding SNDX
# of Institutions
228Shares Held
88.4MCall Options Held
1.01MPut Options Held
692K-
Black Rock Inc. New York, NY7.91MShares$99 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.84MShares$73.2 Million9.23% of portfolio
-
Wellington Management Group LLP Boston, MA4.99MShares$62.4 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$61.2 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.11MShares$51.4 Million6.25% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $708M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...